Jaguar Health Q4 Sales $2.30M Miss $2.61M Estimate
Portfolio Pulse from Benzinga Newsdesk
Jaguar Health (NASDAQ:JAGX) reported Q4 sales of $2.30 million, missing the consensus estimate of $2.61 million by 11.88% and marking a 29.45% decrease from the same period last year.
April 01, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Jaguar Health reported Q4 sales of $2.30 million, missing estimates by 11.88% and experiencing a significant year-over-year decline.
Missing sales estimates and reporting a significant year-over-year decline are negative indicators that could lead to a decrease in investor confidence and potentially lower stock prices in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100